107 related articles for article (PubMed ID: 24024697)
1. Regorafenib use as a possible cause of intestinal perforation.
Adenis A; Kotecki N; Decanter G; Clisant S; Penel N
Acta Oncol; 2013 Nov; 52(8):1789-90. PubMed ID: 24024697
[No Abstract] [Full Text] [Related]
2. [A case of erythema multiforme induced by regorafenib therapy for metastatic colon cancer].
Mii Y; Fukuoka E; Murata K; Otsubo D; Sawa H; Oka S; Iwatani Y; Kuroda D
Gan To Kagaku Ryoho; 2014 Nov; 41(12):1841-3. PubMed ID: 25731348
[TBL] [Abstract][Full Text] [Related]
3. Intestinal perforation after regorafenib usage.
Sarıcı B; Karakaş S; Uylas U; Aktaş A; Dikilitaş M; Kayaalp C
Turk J Gastroenterol; 2018 Mar; 29(2):245-247. PubMed ID: 29749339
[No Abstract] [Full Text] [Related]
4. Regorafenib- associated panniculitis.
Chockalingam R; Aung P; Patel AB
Dermatol Online J; 2016 Jun; 22(6):. PubMed ID: 27617607
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal perforation during regorafenib administration in a case with hepatic metastases of colon cancer.
Ogata K; Takamori H; Umezaki N; Yagi T; Ogawa K; Ozaki N; Hayashi H; Tanaka H; Ikuta Y; Doi K
J Chemother; 2017 Oct; 29(5):314-316. PubMed ID: 27438692
[TBL] [Abstract][Full Text] [Related]
6. Regorafenib in gastrointestinal stromal tumors.
Sirohi B; Philip DS; Shrikhande SV
Future Oncol; 2014; 10(9):1581-7. PubMed ID: 25145429
[TBL] [Abstract][Full Text] [Related]
7. Regorafenib (Stivarga) and gastrointestinal stromal tumours after treatment failure. Radiological improvement but major adverse effects.
Prescrire Int; 2015 Oct; 24(164):234. PubMed ID: 26594725
[TBL] [Abstract][Full Text] [Related]
8. Associations among regorafenib concentrations, severe adverse reactions, and ABCG2 and OATP1B1 polymorphisms.
Maeda A; Irie K; Ando H; Hasegawa A; Taniguchi H; Kadowaki S; Muro K; Tajika M; Aoki M; Inaguma K; Kajita M; Fujimura A; Fukushima S
Cancer Chemother Pharmacol; 2019 Jan; 83(1):107-113. PubMed ID: 30368586
[TBL] [Abstract][Full Text] [Related]
9. Intestinal Perforation in a Patient with Colon Cancer during Treatment with Regorafenib: A Case Report and Review of the Literature.
Ouchi R; Okada K; Usui K; Kurata N; Suzuki S; Nagao M; Watanabe Y; Koyama K
Tohoku J Exp Med; 2021 Jul; 254(3):207-211. PubMed ID: 34321384
[TBL] [Abstract][Full Text] [Related]
10. Regorafenib-induced hyperammonemic encephalopathy.
Kuo JC; Parakh S; Yip D
J Clin Pharm Ther; 2014 Aug; 39(4):446-8. PubMed ID: 24707992
[TBL] [Abstract][Full Text] [Related]
11. [A case of delayed colonic perforation after metallic stent placement for advanced descending colon cancer during bevacizumab-based chemotherapy].
Tanaka I; Hisai H; Miyazaki E; Ono M; Maeda Y; Sato M; Kawasaki R; Gyobu H; Nakajima S; Yamada S; Muramatsu H
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2319-21. PubMed ID: 22202368
[TBL] [Abstract][Full Text] [Related]
12. Single dose regorafenib-induced hypertensive crisis.
Yilmaz B; Kemal Y; Teker F; Kut E; Demirag G; Yucel I
Exp Oncol; 2014 Jun; 36(2):134-5. PubMed ID: 24980770
[TBL] [Abstract][Full Text] [Related]
13. Regorafenib: carving a niche in the crowded therapeutic landscape.
Sirohi B; Philip DS; Shrikhande SV
Expert Rev Anticancer Ther; 2013 Apr; 13(4):385-93. PubMed ID: 23560833
[TBL] [Abstract][Full Text] [Related]
14. Multiple bowel perforations complicating imatinib treatment for advanced gastrointestinal stromal tumor.
Chiarugi M; Galatioto C; Lippolis PV; Seccia M
J Am Coll Surg; 2008 Feb; 206(2):386-7. PubMed ID: 18222396
[No Abstract] [Full Text] [Related]
15. Regorafenib (Stivarga) for metastatic colorectal cancer and GIST.
Med Lett Drugs Ther; 2013 Apr; 55(1415):e36. PubMed ID: 23836345
[No Abstract] [Full Text] [Related]
16. Multi-Targeted Tyrosine Kinase Inhibitor-Induced Hyperammonemic Encephalopathy: a Report of Two Cases Using Pazopanib, Sunitinib, and Regorafenib.
Kongsuphon N; Soukavanitch M; Teeraaumpornpunt N; Konmun J; Ativitavas T; Ngamphaiboon N
J Gastrointest Cancer; 2019 Sep; 50(3):601-603. PubMed ID: 29411249
[No Abstract] [Full Text] [Related]
17. Acute Liver Failure Due to Regorafenib May Be Caused by Impaired Liver Blood Flow: A Case Report.
Akamine T; Ando K; Oki E; Saeki H; Nakashima Y; Imamura YU; Ohgaki K; Maehara Y
Anticancer Res; 2015 Jul; 35(7):4037-41. PubMed ID: 26124352
[TBL] [Abstract][Full Text] [Related]
18. Management of imatinib-related exacerbation of psoriasis in a patient with a gastrointestinal stromal tumour.
Cheng H; Geist DE; Piperdi M; Virk R; Piperdi B
Australas J Dermatol; 2009 Feb; 50(1):41-3. PubMed ID: 19178491
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes and prognostic factors of metastatic gastric carcinoma patients who experience gastrointestinal perforation during palliative chemotherapy.
Kang MH; Kim SN; Kim NK; Park YI; Kim YW; Ryu KW; Lee JH; Lee JS; Park SR
Ann Surg Oncol; 2010 Dec; 17(12):3163-72. PubMed ID: 20585878
[TBL] [Abstract][Full Text] [Related]
20. [Stevens-Johnson syndrome induced by regorafenib in a patient with progressive recurrent rectal carcinoma].
Mihara Y; Yamaguchi K; Nakama T; Nakayama G; Kamei H; Ishibashi N; Uchida S; Akagi Y; Ogata Y
Gan To Kagaku Ryoho; 2015 Feb; 42(2):233-6. PubMed ID: 25743146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
